The Medennium Board of Directors is comprised of experienced, accomplished individuals, represented by leading business, industry, clinical and management professionals.

Jacob Feldman – Chief Executive Officer
Richard Grant – co-founder
Barbara Fant, Pharm.D – Regulatory Consultant
James Zullo – Chief Financial Officer

Medennium LLC – Investment Group


Jacob Feldman, founder of International Vision, Inc. (IVI), has served on the Board of Directors as President and Chief Operating Officer since the company’s inception, and is currently Chief Executive Officer. IVI originally developed the PRL™ Phakic Refractive Lens, which is now being manufactured by Medennium and marketed through CIBA Vision. Mr. Feldman has 20 years of management experience in small businesses and start-up ventures, and spent eight years as an international project manager in the former Soviet Union for Ethicon Endo-Surgery, Inc. (a Johnson & Johnson Company). Mr. Feldman earned his Master’s Degree in Mechanical Engineering at the Engineering Institute USSR.

Richard Grant is a co-founder of International Vision, Inc. (IVI) and has served on the Board of Directors since its inception. Mr. Grant was Director of Product Development for Johnson & Johnson and has 25 years of experience in the Product Development, Quality, and Regulatory divisions of a number of medical device and aircraft companies. Mr. Grant earned his Bachelor's degree in Mathematics and Economics at the West Virginia Institute of Technology. He recently retired from J&J to pursue opportunities in management and his own development company.

Barbara Fant, Pharm.D. has served as a regulatory consultant to International Vision, Inc. (IVI) since January of 1996. She has been involved in new drug development for 14 years, and in ophthalmic device development for the past four years. In 1992, Dr. Fant founded Clinical Research Consultants, Inc., which provides clinical research support services to the pharmaceutical and medical device industries. She is a leading expert in the FDA regulatory process as it relates to excimer lasers and other ophthalmic devices. Dr. Fant specializes in helping start-up companies and investigator/sponsors develop and implement their clinical operating plans and move successfully through the FDA regulatory process. She received a Bachelor’s degree in Pharmacy from Ohio Northern University and a Doctorate in Pharmacy from the University of Cincinnati.

James Zullo is currently the Chief Financial Officer of Medennium, Inc. With over 30 years of comprehensive experience in the ophthalmic/pharmaceutical business, he has directed all facets of finance, accounting and administration management. Mr. Zullo has worked with Medennium since its inception and is also responsible of Human Resources, Customer Service, Sales& Marketing Administration. He received his Bachelor's Degree in Business Administration (Accounting) from California State University - Los Angeles.

  Home Shop Now Dr. Login Contact Us Disclaimer USA Privacy Policy